doi: 10.1136/bmj.1.6125.1466.
Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone
- PMID: 306273
- PMCID: PMC1604940
- DOI: 10.1136/bmj.1.6125.1466
Item in Clipboard
Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone
Br Med J.
.
No abstract available
Similar articles
-
Treatment of the gout and other forms of crystal-induced arthritis.Bull Rheum Dis. 1982;32(5):43-53. Bull Rheum Dis. 1982. PMID: 6762236 Review. No abstract available.
-
Risks and benefits of drugs used in the management and prevention of gout.Drug Saf. 1994 Oct;11(4):252-8. doi: 10.2165/00002018-199411040-00004. Drug Saf. 1994. PMID: 7848545 Review.
-
Drugs for gout.Med Lett Drugs Ther. 1976 Jun 4;18(12):49-51. Med Lett Drugs Ther. 1976. PMID: 934016 No abstract available.
-
The management of gout.Hosp Pract. 1979 Sep;14(9):75-8, 83-5. doi: 10.1080/21548331.1979.11707607. Hosp Pract. 1979. PMID: 478531 No abstract available.
-
Recent developments in the therapy of gout.J Am Geriatr Soc. 1968 May;16(5):499-504. doi: 10.1111/j.1532-5415.1968.tb02088.x. J Am Geriatr Soc. 1968. PMID: 4296544 No abstract available.
Cited by
-
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?Drug Saf. 2008;31(8):643-65. doi: 10.2165/00002018-200831080-00002. Drug Saf. 2008. PMID: 18636784 Review.
-
Phenylbutazone (Bute, PBZ, EPZ): one drug across two species.Hist Philos Life Sci. 2018 Mar 26;40(2):27. doi: 10.1007/s40656-018-0191-4. Hist Philos Life Sci. 2018. PMID: 29582183 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources